Zurcher Kantonalbank (Zurich Cantonalbank) - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 141 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 2.99 and the average weighting 0.1%.

Quarter-by-quarter ownership
Zurcher Kantonalbank (Zurich Cantonalbank) ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$288,649
+9.3%
24,692
+25.7%
0.00%0.0%
Q2 2023$264,069
-18.9%
19,6480.0%0.00%
-50.0%
Q1 2023$325,764
+15.1%
19,648
+29.1%
0.00%0.0%
Q4 2022$283,148
+137.9%
15,223
+64.8%
0.00%
+100.0%
Q3 2022$119,000
+83.1%
9,2400.0%0.00%
Q2 2022$65,000
-52.6%
9,240
-44.1%
0.00%
-100.0%
Q1 2022$137,000
+144.6%
16,535
+99.8%
0.00%
Q4 2021$56,000
+51.4%
8,277
+19.9%
0.00%
Q3 2021$37,000
-7.5%
6,9040.0%0.00%
Q2 2021$40,000
+25.0%
6,9040.0%0.00%
Q1 2021$32,000
+39.1%
6,9040.0%0.00%
Q4 2020$23,000
+9.5%
6,9040.0%0.00%
Q3 2020$21,000
-34.4%
6,9040.0%0.00%
Q2 2020$32,000
+18.5%
6,9040.0%0.00%
Q1 2020$27,000
+3.8%
6,9040.0%0.00%
Q4 2019$26,000
-29.7%
6,9040.0%0.00%
Q3 2019$37,000
+54.2%
6,904
+9.4%
0.00%
Q2 2019$24,0006,3090.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 148,281$2,4587.14%
GABLES CAPITAL MANAGEMENT INC. 409,080$6,782,5464.74%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 10,355,099$171,687,5413.83%
JW Asset Management, LLC 563,392$9,341,0393.58%
Quantedge Capital Pte Ltd 324,700$5,383,5262.10%
Paradiem, LLC 236,628$3,923,2921.22%
SummerHaven Investment Management, LLC 100,592$1,667,8150.97%
Capital Impact Advisors, LLC 46,096$764,2720.94%
Yorktown Management & Research Co Inc 50,000$829,0000.89%
Seaport Global Advisors, LLC 15,598$258,6150.82%
View complete list of CATALYST PHARMACEUTICALS INC shareholders